139 related articles for article (PubMed ID: 17503223)
1. HSP-70 as a nonspecific early marker in cisplatin ototoxicity.
Ramírez-Camacho R; Citores MJ; Trinidad A; Verdaguer JM; García-Berrocal JR; Marero AM; Puente A; González-García JA; Vargas JA
Acta Otolaryngol; 2007 Jun; 127(6):564-7. PubMed ID: 17503223
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration.
Ramírez-Camacho R; Fernández DE; Verdaguer JM; Gómez MM; Trinidad A; García-Berrocal JR; Corvillo MA
Acta Otolaryngol; 2008 May; 128(5):505-9. PubMed ID: 18421602
[TBL] [Abstract][Full Text] [Related]
4. Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Okur E; Kilinc M; Yildirim I; Kilic MA; Tolun FI
Laryngoscope; 2007 Dec; 117(12):2183-6. PubMed ID: 17909450
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
Fang B; Xiao H
Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
[TBL] [Abstract][Full Text] [Related]
7. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
Li G; Liu W; Frenz D
Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
[TBL] [Abstract][Full Text] [Related]
9. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.
Ekborn A; Lindberg A; Laurell G; Wallin I; Eksborg S; Ehrsson H
Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204
[TBL] [Abstract][Full Text] [Related]
11. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress.
Qu J; Li X; Wang J; Mi W; Xie K; Qiu J
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):111-5. PubMed ID: 22055279
[TBL] [Abstract][Full Text] [Related]
12. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
O'Leary SJ; Klis SF
Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
[TBL] [Abstract][Full Text] [Related]
13. Expression of heat shock protein 72 in rat cochlea with cisplatin-induced acute ototoxicity.
Oh SH; Yu WS; Song BH; Lim D; Koo JW; Chang SO; Kim CS
Acta Otolaryngol; 2000 Mar; 120(2):146-50. PubMed ID: 11603760
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on the ototoxicity of cisplatin with distortion products].
Orts Alborch M; García Callejo J; Morant Ventura A; Ferrer Baixauli F; Esparcia Navarro M; Marco Algarra J
Acta Otorrinolaringol Esp; 2000; 51(6):469-77. PubMed ID: 11142781
[TBL] [Abstract][Full Text] [Related]
15. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications.
Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A
Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity.
Waissbluth S; Daniel SJ
Hear Res; 2013 May; 299():37-45. PubMed ID: 23467171
[TBL] [Abstract][Full Text] [Related]
17. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study.
van Ruijven MW; de Groot JC; Klis SF; Smoorenburg GF
Hear Res; 2005 Jul; 205(1-2):241-8. PubMed ID: 15953532
[TBL] [Abstract][Full Text] [Related]
18. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice.
Schmitt NC; Rubel EW
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):614-20. PubMed ID: 23884286
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
Rybak LP
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]